Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Baird Financial Group Inc.

Baird Financial Group Inc. decreased its position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA - Free Report) by 54.4% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 49,126 shares of the pharmacy operator's stock after selling 58,568 shares during the period. Baird Financial Group Inc.'s holdings in Walgreens Boots Alliance were worth $458,000 at the end of the most recent quarter.

A number of other hedge funds also recently bought and sold shares of WBA. Brooklyn Investment Group grew its stake in shares of Walgreens Boots Alliance by 21.1% in the 4th quarter. Brooklyn Investment Group now owns 4,757 shares of the pharmacy operator's stock valued at $44,000 after buying an additional 830 shares during the period. Metis Global Partners LLC lifted its position in Walgreens Boots Alliance by 4.9% in the fourth quarter. Metis Global Partners LLC now owns 23,815 shares of the pharmacy operator's stock valued at $222,000 after purchasing an additional 1,118 shares during the period. Harbour Investments Inc. grew its holdings in shares of Walgreens Boots Alliance by 4.3% in the 4th quarter. Harbour Investments Inc. now owns 28,389 shares of the pharmacy operator's stock worth $265,000 after acquiring an additional 1,165 shares during the period. Unison Advisors LLC lifted its stake in Walgreens Boots Alliance by 2.8% in the 4th quarter. Unison Advisors LLC now owns 43,226 shares of the pharmacy operator's stock valued at $403,000 after buying an additional 1,168 shares in the last quarter. Finally, Avantax Advisory Services Inc. raised its position in shares of Walgreens Boots Alliance by 2.4% in the fourth quarter. Avantax Advisory Services Inc. now owns 49,896 shares of the pharmacy operator's stock valued at $466,000 after buying an additional 1,186 shares during the last quarter. Hedge funds and other institutional investors own 58.59% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts have issued reports on the company. StockNews.com started coverage on Walgreens Boots Alliance in a report on Tuesday, May 13th. They set a "hold" rating on the stock. Truist Financial decreased their price objective on Walgreens Boots Alliance from $13.00 to $12.00 and set a "hold" rating on the stock in a report on Friday, January 31st. Deutsche Bank Aktiengesellschaft lowered shares of Walgreens Boots Alliance from a "hold" rating to a "sell" rating and dropped their price objective for the stock from $11.00 to $9.00 in a report on Friday, February 28th. Finally, Wolfe Research upgraded Walgreens Boots Alliance to a "hold" rating in a research report on Monday, February 24th. Four analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average target price of $10.59.

Insider Buying and Selling at Walgreens Boots Alliance

In other Walgreens Boots Alliance news, Chairman Stefano Pessina bought 832,258 shares of the company's stock in a transaction on Sunday, April 27th. The stock was acquired at an average price of $11.01 per share, for a total transaction of $9,163,160.58. Following the completion of the transaction, the chairman now directly owns 145,621,079 shares of the company's stock, valued at approximately $1,603,288,079.79. This represents a 0.57% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 17.50% of the company's stock.

Walgreens Boots Alliance Stock Performance

Shares of NASDAQ:WBA traded down $0.04 during mid-day trading on Monday, reaching $11.25. The company had a trading volume of 3,653,851 shares, compared to its average volume of 21,046,947. Walgreens Boots Alliance, Inc. has a one year low of $8.08 and a one year high of $18.17. The company has a current ratio of 0.64, a quick ratio of 0.30 and a debt-to-equity ratio of 0.68. The company's 50-day moving average price is $11.02 and its 200-day moving average price is $10.36. The firm has a market cap of $9.73 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.77.

Walgreens Boots Alliance (NASDAQ:WBA - Get Free Report) last posted its quarterly earnings data on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.53 by $0.10. The firm had revenue of $38.59 billion during the quarter, compared to analysts' expectations of $37.90 billion. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company's revenue for the quarter was up 4.1% compared to the same quarter last year. During the same period in the prior year, the business earned $1.20 EPS. As a group, equities research analysts anticipate that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current fiscal year.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.